Many monoclonal antibodies (mAbs) have been extensively used in the clinic, such as rituximab to treat lymphoma. However, resistance and non-responsiveness to mAb treatment have been challenging for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results